Literature DB >> 15136581

Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease.

Fumiaki Banno1, Kazuyoshi Kaminaka, Kenji Soejima, Koichi Kokame, Toshiyuki Miyata.   

Abstract

Human ADAMTS13 was recently identified as a gene encoding von Willebrand factor-cleaving protease, hADAMTS13. Both congenital and acquired defects in this enzyme can cause thrombotic thrombocytopenic purpura. hADAMTS13 consists of 1,427 amino acid residues and is composed of multiple structural domains including thrombospondin type 1 motifs and CUB domains. To analyze the functional roles of these domains in vivo, we determined the cDNA sequence of the mouse ortholog, mADAMTS13. Unexpectedly, two forms of the mouse Adamts13 gene were isolated that differed in the insertion of an intracisternal A particle (IAP) retrotransposon including a premature stop codon. The IAP insertion was found in BALB/c, C3H/He, C57BL/6, and DBA/2 strains but not in the 129/Sv strain. The outbred ICR strain had either the IAP-free or IAP-inserted allele or both. IAP-free Adamts13 encoded mADAMTS13L, a protein of 1,426 amino acid residues with the same domain organization as hADAMTS13. In contrast, IAP-inserted Adamts13 encoded a C-terminally truncated enzyme, mADAMTS13S, that is comprised of only 1,037 amino acid residues and lacking the C-terminal two thrombospondin type 1 motifs and two CUB domains. Strain specificity was also confirmed by reverse transcription-PCR and Northern blot analyses. Both recombinant mADAMTS13L and mADAMTS13S exhibited von Willebrand factor cleaving activities in vitro. The natural variation in mouse ADAMTS13 should allow for the determination of hitherto unknown functions of its C-terminal domains in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136581     DOI: 10.1074/jbc.M314184200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.

Authors:  David G Motto; Anil K Chauhan; Guojing Zhu; Jonathon Homeister; Colin B Lamb; Karl C Desch; Weirui Zhang; Han-Mou Tsai; Denisa D Wagner; David Ginsburg
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

2.  Allosteric activation of ADAMTS13 by von Willebrand factor.

Authors:  Joshua Muia; Jian Zhu; Garima Gupta; Sandra L Haberichter; Kenneth D Friedman; Hendrik B Feys; Louis Deforche; Karen Vanhoorelbeke; Lisa A Westfield; Robyn Roth; Niraj Harish Tolia; John E Heuser; J Evan Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

3.  Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.

Authors:  C M Pruss; M Golder; A Bryant; C Hegadorn; S Haberichter; D Lillicrap
Journal:  J Thromb Haemost       Date:  2012-05       Impact factor: 5.824

4.  Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models.

Authors:  Cynthia M Pruss; Mia Golder; Andrea Bryant; Carol A Hegadorn; Erin Burnett; Kimberly Laverty; Kate Sponagle; Aly Dhala; Colleen Notley; Sandra Haberichter; David Lillicrap
Journal:  Blood       Date:  2011-02-23       Impact factor: 22.113

5.  Two novel heterozygote missense mutations of the ADAMTS13 gene in a child with recurrent thrombotic thrombocytopenic purpura.

Authors:  Raffaella Rossio; Barbara Ferrari; Andrea Cairo; Ilaria Mancini; Giovanni Pisapia; Giulia Palazzo; Flora Peyvandi
Journal:  Blood Transfus       Date:  2012-09-12       Impact factor: 3.443

6.  ADAMTS13 is expressed in hepatic stellate cells.

Authors:  Wenhua Zhou; Mari Inada; Tai-Ping Lee; Daniel Benten; Sergey Lyubsky; Eric E Bouhassira; Sanjeev Gupta; Han-Mou Tsai
Journal:  Lab Invest       Date:  2005-06       Impact factor: 5.662

7.  ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice.

Authors:  Chintan Gandhi; Mohammad Moshahid Khan; Steven R Lentz; Anil K Chauhan
Journal:  Blood       Date:  2011-11-28       Impact factor: 22.113

Review 8.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

9.  Modeling the neurovascular niche: murine strain differences mimic the range of responses to chronic hypoxia in the premature newborn.

Authors:  Qi Li; Michael Michaud; William Stewart; Michael Schwartz; Joseph A Madri
Journal:  J Neurosci Res       Date:  2008-05-01       Impact factor: 4.164

10.  ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice.

Authors:  Chintan Gandhi; David G Motto; Melissa Jensen; Steven R Lentz; Anil K Chauhan
Journal:  Blood       Date:  2012-09-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.